European Journal of Clinical Pharmacology

, Volume 23, Issue 5, pp 423–427 | Cite as

Dipyridamole treatment in chronic obstructive airways disease: Effect on platelet regeneration time

  • E. Tremoli
  • L. Bertoli
  • R. Merlini
  • S. Colli
  • P. Maderna
  • O. Mantero
  • C. R. Sirtori
Originals

Summary

The platelet regeneration time (PRT) determined in a group of hypoxaemic patients with chronic obstructive airways disease (COAD), before and after treatment with dipyridamole 150 mg tid, was compared with a group of control subjects. The PRT was computed by a modified non-radioisotope technique and was expressed as t1/2 in days. The patient group showed a significantly shortened PRT as compared to controls of the same age and sex (2.10±0.16 vs 3.65±0.26 days;p<0.001). One month of dipyridamole administration resulted in prolongation of the PRT in COAD patients (2.10±0.16 days pre-treatment vs 2.75±0.20 post-treatment;p<0.01), without affecting the platelet cyclo-oxygenase system. This study indicates that dipyridamole may be beneficial in pathological conditions, which are characterized by increased platelet turnover, possibly leading to frequent thromboembolic complications.

Key words

chronic obstructive airways disease dipyridamole pulmonary thromboembolism platelet regeneration time 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Magri G, Catenazzo G, Mignone V, Longhini E (1973) Insuffisance réspiratoire de la broncho-pneumonathie chronique et maladie thromboémbolique. Poumon Coeur 29: 183–189Google Scholar
  2. 2.
    Mitchell RS, Silvers GW, Dart GA, Petty TL, Vincent TN, Ryad SF, Filley GF (1968) Clinical and morphologic correlation in chronic airways obstruction. Am Rev Respir Dis 97: 54–60Google Scholar
  3. 3.
    Steele P, Ellis HJ Jr, Weily HS, Genton E (1977) Platelet survival time in patients with hypoxemia and pulmonary hypertension. Circulation 55: 660–662Google Scholar
  4. 4.
    Mlczoch J, Tucker A, Kenneth-Weir E, Reeves JT, Grover RF (1978) Platelet-mediated pulmonary hypertension and hypoxia during pulmonary microembolism. Chest 74: 648–653Google Scholar
  5. 5.
    Ross R, Glomset J, Kariya B, Harker L (1974) A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells “in vitro”. Proc Natl Acad Sci, USA 71: 1207–1210Google Scholar
  6. 6.
    Ross R, Glomset JA (1976) The pathogenesis of atherosclerosis. N Engl J Med 295: 369–425Google Scholar
  7. 7.
    Born GVR, Mills DCB (1969) Potentiation of the inhibitory effect of adenosine on platelet aggregation by drugs that prevent its uptake. J Physiol (Lond) 202: 41P-42PGoogle Scholar
  8. 8.
    McElroy FA, Philip RB (1975) Relative potencies of dipyridamole and related agents as inhibitors of cyclic nucleotide phosphodiesterases: possible explanation of mechanism of inhibition of platelet function. Life Sci 17: 1479–1493Google Scholar
  9. 9.
    Moncada S, Korbut R (1978) Dipyridamole and other phosphodiesterase inhibitors act as antithrombotic agents by potentiating endogenous prostacyclin. Lancet 1: 1286–1289Google Scholar
  10. 10.
    Harker LA, Slichter SJ (1973) Arterial thromboembolism: quantitation and prevention. Proc IV Int Congress on Thrombosis and Haemostasis. Wien, p 170Google Scholar
  11. 11.
    Harker LA, Ross R, Slichter SJ, Scott CR (1976) Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis. J Clin Invest 58: 731–741Google Scholar
  12. 12.
    Stuart MJ, Murphy S, Oski FA (1975) A simple nonradioisotope technique for the determination of platelet life-span. N Engl J Med 292: 1310–1313Google Scholar
  13. 13.
    Nomenclature and definitions in respiratory physiology and clinical aspects of chronic lung disease (1975) Bull Physio-Pathol Respir 11: 937–940Google Scholar
  14. 14.
    Smith JB, Ingerman CM, Silver MJ (1976) Malondialdehyde formation as an indicator of prostaglandin production by human platelet. J Lab Clin Med 88: 167–172Google Scholar
  15. 15.
    Rajah SM, Crow MJ, Penny AF, Ahmad R, Watson DA (1977) The effect of dipyridamole on platelet function: correlation with blood levels in man. Br J Clin Pharmacol 4: 129–133Google Scholar
  16. 16.
    Wagenvoort CA, Wagenvoort N (1977) Pathology of pulmonary hypertension. Wiley, New York, pp 128–130Google Scholar
  17. 17.
    Smith U, Ryan JW, Michie DD, Smith DS (1971) Endothelial projections as revealed by scanning electron-microscopy. Science 173: 925–928Google Scholar
  18. 18.
    Fishman AP (1976) State of the art-chronic corpulmonale. Am Rev Respir Dis 114: 775–794Google Scholar
  19. 19.
    Sykes MK, McNicol MW, Campbell EJM (1972) L'insufficienza respiratoria: fisiopatologia, clinica e terapia. Piccin Editore, Padova. (Original title: “Respiratory failure”. Blackwell, Oxford, p 75)Google Scholar
  20. 20.
    Mustala OO, Azarnoff DL (1969) Effect of oxygen tension on drug levels and pharmacological action in the intact animal. Proc Soc Exp Biol Med 132: 37–41Google Scholar
  21. 21.
    Preston FE, Whipps S, Jackson CA, French AJ, Wyld PJ, Stoddard CJ (1981) Inhibition of prostacyclin and platelet thromboxane A2 after low-dose aspirin. N Engl J Med 304: 76–79Google Scholar
  22. 22.
    Roth GJ, Stanford N, Majerus PW (1975) Acetylation of prostaglandin synthase by aspirin. Proc Natl Acad Sci USA 72: 3073–3078Google Scholar
  23. 23.
    Tyce GM, Fuster V, Owen CA Jr (1979) Dipyridamole levels in plasma of man and other species. Res Commun Chem Pathol Pharmacol 26: 495–508Google Scholar
  24. 24.
    Mlczoch J, Kenneth E, Grover RF (1977) Inhibition of hypoxic pulmonary vasoconstriction by dipyridamole is not platelet mediated. Can J Physiol Pharmacol 55: 448–453Google Scholar
  25. 25.
    Neri Serneri GG, Masotti G, Poggesi L, Galanti G, Morettini A (1981) Enhanced prostacyclin production by dipyridamole in man. Eur J Clin Pharmacol 21: 9–15Google Scholar
  26. 26.
    Crutchley DJ, Ryan US, Ryan JW (1980) Effects of aspirin and dipyridamole on the degradation of adenosine diphosphate by cultured cells derived from bovine pulmonary artery. J Clin Invest 66: 29–35Google Scholar

Copyright information

© Springer-Verlag 1982

Authors and Affiliations

  • E. Tremoli
    • 1
  • L. Bertoli
    • 2
  • R. Merlini
    • 2
  • S. Colli
    • 1
  • P. Maderna
    • 1
  • O. Mantero
    • 2
  • C. R. Sirtori
    • 1
  1. 1.E. Grossi Paoletti CentreUniversity of MilanMilanItaly
  2. 2.Vergani DivisionHospital of NiguardaMilanItaly

Personalised recommendations